Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease
Authors:
- Lin LuLLLin Lu
- Jian HuJHJian Hu
- Rui Yan ZhangRZRui Yan Zhang
- Qi ZhangQZQi Zhang
- Qiu Jin ChenQCQiu Jin Chen
- Wei Feng ShenWSWei Feng Shen
- 1 June 2010
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 210 (2) , 590-595
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Science and Technology Foundation (05DZ19503)
This publication has 31 references indexed in Scilit:
- Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetesAtherosclerosis, 2009
- YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of AlbuminuriaDiabetes Care, 2009
- C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target?Clinical Chemistry, 2009
- Plasma YKL-40Diabetes, 2008
- High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortalityClinical and Experimental Immunology, 2007
- Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI TrialHeart, 2006
- Inflammatory Biomarkers in Stable AtherosclerosisThe American Journal of Cardiology, 2006
- Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery DiseaseCirculation, 2006
- In Vitro Biomarker Discovery for Atherosclerosis by ProteomicsMolecular & Cellular Proteomics, 2004
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1987